Pandemic Prevention and Innovation Summit | Kisaco Research

The Pandemic Prevention and Innovation Summit

Accelerating innovation in technology and therapeutics to improve global pandemic preparedness

Find out more
Virtual Summit
9 March, 2021

“Will we simply respond to the here and now, or do we take a moment to stop, look up & see beyond the horizon of this pandemic towards the next one?”

Dame Sally Davies, former CMO for England [The Guardian 26/09/20]

The Pandemic Prevention and Innovation Summit will be co-located with the Phage Futures Congress.

Why Attend

In light of the current Covid-19 pandemic, join us on March 1, 2021 for the inaugural Pandemic Prevention & Innovation Summit as we bring together leading figures from the private, public, philanthropic & civil service sectors to participate in open discussion focused on how we can be better prepared for future pandemics through innovative technology & therapeutics.

Discover new fields for viable investment in the infectious disease space through an expert lens, as they identify areas of innovation which have been successful in past pandemic responses & new areas which could see disruption in future pandemic responses.

During the summit, learn of global collaborative initiatives promoting the development of R&D in pandemic preparedness. Following the interactive sessions, identify solution providers from the attendee list for your unique organisation needs & simply connect with them through our private meeting scheduler, available to all participants. Finally, get the chance to participate in exclusive interactive discussions led by key speakers, including representatives from the WHO & Council on Strategic Risks.

Who Will Be There

20%
Biotech
10%
Service Providers
25%
Pharma
25%
Academics
10%
Investors and Accelerators

Biotech

Service Providers

Pharma

Academics

Investors and Accelerators

Portfolio attendees

Early Confirmed Speakers

 

Andrew Weber

Senior Fellow
The Council on Strategic Risks

Andrew Weber

Senior Fellow
The Council on Strategic Risks

Andrew Weber

Senior Fellow
The Council on Strategic Risks
 

Dr Peter Beyer

Unit Head, Antimicrobial Resistance Division
WHO

Peter Beyer, a trained lawyer, is a Senior Advisor with the World Health Organization (WHO) in Geneva where he leads a team working on global initiatives on antimicrobial resistance. He focuses on developing global instruments to combat antimicrobial resistance and to foster the development of new antimicrobial treatments.

Dr Peter Beyer

Unit Head, Antimicrobial Resistance Division
WHO

Dr Peter Beyer

Unit Head, Antimicrobial Resistance Division
WHO

Peter Beyer, a trained lawyer, is a Senior Advisor with the World Health Organization (WHO) in Geneva where he leads a team working on global initiatives on antimicrobial resistance. He focuses on developing global instruments to combat antimicrobial resistance and to foster the development of new antimicrobial treatments. Peter was instrumental in setting up the Global Antibiotic R&D Partnership (GARDP), a foundation that is developing new antibacterial treatments as well as the trilateral collaboration among the World Intellectual Property Organization (WIPO), the World Trade Organization (WTO) and WHO. Previously, Peter Beyer was a Legal Advisor to the Swiss Federal Institute of Intellectual Property in Berne. He negotiated bilateral free trade agreements for the European Free Trade Association (EFTA) and was responsible for the bilateral dialogue between Switzerland and China on intellectual property. Prior to joining the Swiss civil service, Peter Beyer worked with the Ecologic Institute in Berlin on environmental law and policy.

 

Dr Erin Duffy

Chief of Research & Development
CARB-X

Dr Erin Duffy

Chief of Research & Development
CARB-X

Dr Erin Duffy

Chief of Research & Development
CARB-X
 

Dr Rashid Chotani

Medical Director
IEM

Dr Rashid Chotani

Medical Director
IEM

Dr Rashid Chotani

Medical Director
IEM
 

Dr Milana Boukhman Trounce

Director of Biosecurity & Pandemic Resilience & Response, Clinical Professor of Emergency Medicine
Stanford University

Dr Milana Boukhman Trounce

Director of Biosecurity & Pandemic Resilience & Response, Clinical Professor of Emergency Medicine
Stanford University

Dr Milana Boukhman Trounce

Director of Biosecurity & Pandemic Resilience & Response, Clinical Professor of Emergency Medicine
Stanford University
 

Nita Madhav

Chief Executive Officer
Metabiota

Nita Madhav

Chief Executive Officer
Metabiota

Nita Madhav

Chief Executive Officer
Metabiota
 

Dr Dennis Carroll

Chair of Leadership Board
Global Virome Project

Dr Dennis Carroll

Chair of Leadership Board
Global Virome Project

Dr Dennis Carroll

Chair of Leadership Board
Global Virome Project
 

Dr Robert Johnson

Director of Influenza & Emerging Infectious Diseases Division
BARDA

Dr Robert Johnson

Director of Influenza & Emerging Infectious Diseases Division
BARDA

Dr Robert Johnson

Director of Influenza & Emerging Infectious Diseases Division
BARDA
 

Jeremy Knox

Policy & Advocacy Lead Drug Resistant Infections Division
Wellcome Trust

Jeremy Knox

Policy & Advocacy Lead Drug Resistant Infections Division
Wellcome Trust

Jeremy Knox

Policy & Advocacy Lead Drug Resistant Infections Division
Wellcome Trust
 

Julia Barnes-Weise

Executive Director
Global Healthcare Innovation Alliance Accelerator

Julia Barnes-Weise

Executive Director
Global Healthcare Innovation Alliance Accelerator

Julia Barnes-Weise

Executive Director
Global Healthcare Innovation Alliance Accelerator

Become a Sponsor

Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].

The Virtual Experience

Top 10 benefits

- Tailor Your Agenda 

- More Audience Participation

- Improved Audience Visibility 

- On-Demand Content

- High Quality Speakers 

- More Networking Opportunities 

- Save Time & Money 

- Increased Content 

- More insights 

- Business Development Opportunities - Talk to our team to find out out more [email protected].

Platform Preview

The Agenda

Fill in your details to download a copy of the Pandemic Prevention and Innovation Summit agenda to understand the topics being covered and why you should attend.

Agenda launched!

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:
Wednesday, December 16, 2020 to Friday, January 22, 2021
Super Early Bird - Academic / Clinicians / Government
$99
Super Early Bird available until January 22. Save $200.
This pass will give you access to all live content, 1-2-1 meetings and on-demand content across the 1 day event.
To increase your brand presence, contact [email protected]
Wednesday, December 16, 2020 to Friday, January 22, 2021
Super Early Bird - Biotechs / Pharma
$199
Super Early Bird available until January 22. Save $200.
This pass will give you access to all live content, 1-2-1 meetings and on-demand content across the 1 day event.
To increase your brand presence, contact [email protected]
Wednesday, December 16, 2020 to Friday, January 22, 2021
Super Early Bird - Service Providers
$299
Super Early Bird available until January 22. Save $400.
This pass will give you access to all live content, 1-2-1 meetings and on-demand content across the 1 day event.
To increase your brand presence, contact [email protected]
Preparing registration...

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Other events you might be interested in:

Phage Futures 2021